98 related articles for article (PubMed ID: 8386094)
1. Lack of cross-tolerance between nitroglycerin and endothelium-derived relaxing factor-mediated vasoactive agents in spontaneously hypertensive rats.
De Garavilla L; Volberg ML; Pratt PF; Silver PJ; Buchholz RA
Eur J Pharmacol; 1993 Mar; 234(1):77-82. PubMed ID: 8386094
[TBL] [Abstract][Full Text] [Related]
2. Zaprinast, but not dipyridamole, reverses hemodynamic tolerance to nitroglycerin in vivo.
De Garavilla L; Pagani ED; Buchholz RA; Dundore R; Bode DC; Volberg ML; Jackson KN; Pratt P; Silver PJ
Eur J Pharmacol; 1996 Oct; 313(1-2):89-96. PubMed ID: 8905333
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor.
Merkel LA; Rivera LM; Perrone MH; Lappe RW
Eur J Pharmacol; 1992 May; 216(1):29-35. PubMed ID: 1326438
[TBL] [Abstract][Full Text] [Related]
4. N omega-nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast.
Dundore RL; Pratt PF; O'Connor B; Buchholz RA; Pagani ED
Eur J Pharmacol; 1991 Jul; 200(1):83-7. PubMed ID: 1663042
[TBL] [Abstract][Full Text] [Related]
5. Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.
Silver PJ; Dundore RL; Bode DC; de Garavilla L; Buchholz RA; van Aller G; Hamel LT; Bacon E; Singh B; Lesher GY
J Pharmacol Exp Ther; 1994 Dec; 271(3):1143-9. PubMed ID: 7996419
[TBL] [Abstract][Full Text] [Related]
6. Reversal or nitroglycerin tolerance by the cGMP phosphodiesterase inhibitor zaprinast.
Silver PJ; Pagani ED; de Garavilla L; Van Aller GS; Volberg ML; Pratt PF; Buchholz RA
Eur J Pharmacol; 1991 Jun; 199(1):141-2. PubMed ID: 1654265
[No Abstract] [Full Text] [Related]
7. M&B 22948, a cGMP phosphodiesterase inhibitor, is a pulmonary vasodilator in lambs.
Braner DA; Fineman JR; Chang R; Soifer SJ
Am J Physiol; 1993 Jan; 264(1 Pt 2):H252-8. PubMed ID: 8381611
[TBL] [Abstract][Full Text] [Related]
8. Reversal of nitroglycerin tolerance in vitro by the cGMP-phosphodiesterase inhibitor zaprinast.
Pagani ED; VanAller GS; O'Connor B; Silver PJ
Eur J Pharmacol; 1993 Oct; 243(2):141-7. PubMed ID: 8276063
[TBL] [Abstract][Full Text] [Related]
9. Cilazapril reverses endothelium-dependent vasodilator response to acetylcholine in mesenteric artery from spontaneously hypertensive rats.
Young RH; Ding YA; Lee YM; Yen MH
Am J Hypertens; 1995 Sep; 8(9):928-33. PubMed ID: 8541009
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle.
Harris AL; Lemp BM; Bentley RG; Perrone MH; Hamel LT; Silver PJ
J Pharmacol Exp Ther; 1989 May; 249(2):394-400. PubMed ID: 2566675
[TBL] [Abstract][Full Text] [Related]
11. L-Arginine, a precursor of EDRF in vitro, produces pulmonary vasodilation in lambs.
Fineman JR; Chang R; Soifer SJ
Am J Physiol; 1991 Nov; 261(5 Pt 2):H1563-9. PubMed ID: 1659228
[TBL] [Abstract][Full Text] [Related]
12. Chronic exercise enhances endothelium-mediated dilation in spontaneously hypertensive rats.
Yen MH; Yang JH; Sheu JR; Lee YM; Ding YA
Life Sci; 1995; 57(24):2205-13. PubMed ID: 7475973
[TBL] [Abstract][Full Text] [Related]
13. Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-L-arginine methyl ester.
Gardiner SM; Compton AM; Kemp PA; Bennett T
Br J Pharmacol; 1990 Nov; 101(3):632-9. PubMed ID: 2127552
[TBL] [Abstract][Full Text] [Related]
14. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
Resende AC; Pimentel AM; de Moura RS
Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389
[TBL] [Abstract][Full Text] [Related]
15. EDHF-mediated rapid restoration of hypotensive response to acetylcholine after chronic, but not acute, nitric oxide synthase inhibition in rats.
Desai KM; Gopalakrishnan V; Hiebert LM; McNeill JR; Wilson TW
Eur J Pharmacol; 2006 Sep; 546(1-3):120-6. PubMed ID: 16876156
[TBL] [Abstract][Full Text] [Related]
16. N omega-nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs.
Fineman JR; Heymann MA; Soifer SJ
Am J Physiol; 1991 Apr; 260(4 Pt 2):H1299-306. PubMed ID: 1849373
[TBL] [Abstract][Full Text] [Related]
17. The vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, is impaired in conscious spontaneously hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):476-90. PubMed ID: 16697269
[TBL] [Abstract][Full Text] [Related]
18. K+ channel pulmonary vasodilation in fetal lambs: role of endothelium-derived nitric oxide.
Chang JK; Moore P; Fineman JR; Soifer SJ; Heymann MA
J Appl Physiol (1985); 1992 Jul; 73(1):188-94. PubMed ID: 1506367
[TBL] [Abstract][Full Text] [Related]
19. Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats.
Dundore RL; Clas DM; Wheeler LT; Habeeb PG; Bode DC; Buchholz RA; Silver PJ; Pagani ED
Eur J Pharmacol; 1993 Nov; 249(3):293-7. PubMed ID: 8287916
[TBL] [Abstract][Full Text] [Related]
20. Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension.
Mayhan WG
Am J Physiol; 1990 Nov; 259(5 Pt 2):H1455-62. PubMed ID: 2122745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
